muscle
• in tibialis anterior (TA) muscles at 6 months and rectus femoris (RF) muscles at 6 and 18 months
|
• in tibialis anterior (TA) muscles at 18 months
|
• in tibialis anterior (TA) muscles at 6 months
• in rectus femoris (RF) muscles at 6 and 18 months and tibialis anterior (TA) muscles at 18 months
|
• in anterior (TA) muscles at 6 months and rectus femoris (RF) muscles at 6 and 18 months
|
• in tibialis anterior (TA) muscles at 18 months
|
cellular
• reduced expression of mitochondrial proteins in rectus femoris (RF) muscles at 3 months
|
• significantly reduced levels of SDHB (Complex II), COX1 (Complex IV), and ATP5A (Complex V) proteins in rectus femoris (RF) muscles at 3 months
• significantly reduced succinate dehydrogenase activity (SDH, Complex II) in rectus femoris (RF) muscles using nitro blue tetrazolium assay
• succinate dehydrogenase activity (SDH, Complex II) in tibialis anterior (TA) muscles using nitro blue tetrazolium assay
• significantly reduced NADH:ubiquinone oxidoreductase (Complex I) activity in rectus femoris (RF) muscles at 12 months
|
homeostasis/metabolism
• decreased RNA poly(A) tail length at 3 months: longest poly(A) tails reduced by 20% in length
|
behavior/neurological
• hind limbs from age 9 months
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
oculopharyngeal muscular dystrophy | DOID:11719 |
OMIM:164300 |
J:243638 |